Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.
Category: Health Industry
Medicare Advantage Plans Shift Their Financial Risk To Doctors
Some private Medicare Advantage plans are offering large physician-management companies more money upfront and control of their patients’ care, but the doctors are responsible for staying within the budget.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Patient Advocacy Or Political Ploy? Union, Industry Square Off Over Dialysis Initiative
The measure, which will appear on the November ballot, seeks to cap industry profits. The SEIU-UHW union has raised almost $17 million, but industry opponents have invested more than four times that.
In The Battle To Control Drug Costs, Old Patent Laws Get New Life
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
Pharmaceutical companies like Purdue Pharma, maker of OxyContin, often win patents for incremental changes with debatable value. Now there’s a twist involving an opioid treatment.
Feds Settle Huge Whistleblower Suit Over Medicare Advantage Fraud
A DaVita subsidiary will pay $270 million over allegations that it cheated the federal government for years.
White Coats As Superhero Capes: Med Students Swoop In To Save Health Care
Students from eight medical schools in and around New York City attended a conference Sept. 23 on progressive activism during their training years — and beyond.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
‘Contraception Deserts’ Likely To Widen Under New Trump Administration Policy
Federal family planning funds, known as Title X, will soon fund for-profit women’s clinics that bar condoms, hormonal birth control and IUDs and offer only “natural family planning.”
